Är du en teknikintresserad problemlösare med djup kunskap inom Linux och en stark känsla för IT-säkerhet? Nu söker...-Drifttekniker kommer du att: Felsöka och hantera Linux-system, med särskilt fokus på Red Hat/Linux. Utföra Ansible deployment...
system (XCS) and is a Linux based control system. We can offer a rich number of opportunities in an everyday learning... in Linux user space and kernel space, incl. driver development Experience from SW development in a Linux environment using e.g...
Är du expert på Linux och Windows Server? Ta nästa steg i din IT-karriär! Vi söker en engagerad och kunnig Server... Operations Specialist med expertis inom både Linux och Windows Server som vill bidra till att forma framtidens IT-lösningar...
flera erfarna Embedded Linux Engineers till våra team i Göteborg. Hos oss får du chansen att utveckla och implementera.... I din roll som Embedded Linux Engineer kommer du att: Utveckla och implementera mjukvarulösningar för inbyggda system Arbeta...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »